The Molecular and Cellular Mechanisms of Endometriosis: From Basic Pathophysiology to Clinical Implications
International Journal of Molecular Sciences · 10.03.2025 · 26 (6) · 2458
DOI: 10.3390/ijms26062458 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.03.2025. Verfasst von Heidi Mariadas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Taipei Tzu-Chi Hospital, The Buddhist Tzu-Chi Medical Foundation, New Taipei City 23142, Taiwan. Hauptthemen laut MEDLINE: Endometriosis. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taipei Tzu Chi Hospital, Taipei Tzu-Chi Hospital, Taiwan.
Abstract (Originalsprache)
Endometriosis is a complex gynecological disorder characterized by endometrial-like tissue growing outside the uterus, leading to chronic pain, infertility, and reduced quality of life. Its pathophysiology involves genetic, epigenetic, immune, and molecular factors. Theories such as retrograde menstruation, coelomic metaplasia, and stem cell involvement explain lesion formation. Endometrial mesenchymal stem cells (eMSCs) and epithelial progenitors (eEPs) contribute to lesion establishment by adhering to peritoneal surfaces, proliferating, and differentiating into ectopic tissue. Aberrant adhesion molecules, inflammatory cytokines, and molecular pathways like PI3K/Akt and Wnt/β-catenin drive proliferation, angiogenesis, and resistance to apoptosis. Elevated estrogen levels and progesterone resistance further promote lesion growth and immune evasion. Immune dysfunction, including altered macrophage activity and reduced natural killer (NK) cell function, contributes to inflammation and lesion persistence. Pain is linked to prostaglandin E2 (PGE2) and nerve infiltration, emphasizing the need for targeted pain management. Current therapies, such as GnRH agonists, suppress ovarian hormone production but face limitations in long-term efficacy and side effects. Integrating molecular insights into clinical practice may advance diagnostics and treatment, with emerging approaches focusing on molecular pathways, immune modulation, and hormonal regulation for more effective, personalized therapies. Future research should unravel the complex mechanisms driving endometriosis to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Taipei Tzu-Chi Hospital, The Buddhist Tzu-Chi Medical Foundation, New Taipei City 23142, Taiwan.
- Department of Medicine, MacKay Medical College, New Taipei City 25245, Taiwan.
- School of Medicine, Tzu-Chi University, Hualien 97004, Taiwan.
ORCID-Profile: Kuo-Hu Chen
Förderung
- Taipei Tzu Chi Hospital
- Taipei Tzu-Chi Hospital, Taiwan
Zitieren
APA
Mariadas, H., Chen, J. H., & Chen, K. H. (2025). The Molecular and Cellular Mechanisms of Endometriosis: From Basic Pathophysiology to Clinical Implications. International Journal of Molecular Sciences, 26(6), 2458. https://doi.org/10.3390/ijms26062458
Vancouver
Mariadas H, Chen JH, Chen KH. The Molecular and Cellular Mechanisms of Endometriosis: From Basic Pathophysiology to Clinical Implications. International Journal of Molecular Sciences. 2025;26(6):2458. doi:10.3390/ijms26062458
BibTeX
@article{Mariadas2025,
author = {Mariadas, Heidi and Chen, Jie-Hong and Chen, Kuo-Hu},
title = {The Molecular and Cellular Mechanisms of Endometriosis: From Basic Pathophysiology to Clinical Implications},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {6},
pages = {2458},
doi = {10.3390/ijms26062458}
}
EUVIMED